Oxidative Stress and Cytokines in the Pathogenesis of Pancreatic Cancer

Overview

Journal J Cancer Prev

Specialty Oncology

Date 2014 Oct 23

PMID 25337577

Citations 18

Authors

Ji Hoon Yu

Hyeyoung Kim

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer is one of the most aggressive, drug-resistant and lethal types of cancer with poor prognosis. Various factors including reactive oxygen species, cytokines, growth factors, and extracellular matrix proteins are reported to be involved in the development of pancreatic cancer. However, the pathogenesis of pancreatic cancer has not been completely elucidated. Oxidative stress has been shown to contribute to the development of pancreatic cancer. Evidences supporting the role of reactive oxygen species and cytokines as a risk for pancreatic cancer and the concept of antioxidant supplementation as a preventive approach for pancreatic cancer have been proposed. Here, we review the literature on oxidative stress, cytokine expression, inflammatory signaling, and natural antioxidant supplementation in relation to pancreatic cancer.

Citing Articles

Identification of immune- and oxidative stress-related signature genes as potential targets for mRNA vaccines for pancreatic cancer patients.

Li J, Han Y, Zhao N, Lv L, Ma P, Zhang Y Medicine (Baltimore). 2024; 103(27):e38666.

PMID: 38968513 PMC: 11224846. DOI: 10.1097/MD.0000000000038666.

Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.

Wang H, Guo H, Sun J, Wang Y Sci Rep. 2023; 13(1):13564.

PMID: 37604837 PMC: 10442332. DOI: 10.1038/s41598-023-40560-4.

A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma.

Wang H, Tian R, Liang X, Fan J, Duan Z, Fan X Front Oncol. 2023; 12:1015042.

PMID: 36713541 PMC: 9880292. DOI: 10.3389/fonc.2022.1015042.

Pancreatic Cancer and Microenvironments: Implications of Anesthesia.

Lai H, Kuo Y, Huang Y, Chan S, Cheng K, Wu Z Cancers (Basel). 2022; 14(11).

PMID: 35681664 PMC: 9179559. DOI: 10.3390/cancers14112684.

Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer.

Ortega M, Fraile-Martinez O, Pekarek L, Garcia-Montero C, Alvarez-Mon M, Castellanos A Antioxidants (Basel). 2022; 11(4).

PMID: 35453444 PMC: 9029757. DOI: 10.3390/antiox11040759.

References

Sun X, Liu X, Huang D . Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol Rep. 2013; 29(6):2401-7. DOI: 10.3892/or.2013.2385. View

Miron N, Miron M, Milea V, Cristea V . Proinflammatory cytokines: an insight into pancreatic oncogenesis. Roum Arch Microbiol Immunol. 2011; 69(4):183-9. View

Greco E, Basso D, Fogar P, Mazza S, Navaglia F, Zambon C . Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1. Int J Biol Markers. 2006; 20(4):235-41. DOI: 10.1177/172460080502000406. View

Bellone G, Smirne C, Mauri F, Tonel E, Carbone A, Buffolino A . Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol Immunother. 2005; 55(6):684-98. PMC: 11031060. DOI: 10.1007/s00262-005-0047-0. View

Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J . Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 2007; 26(6B):4423-30. View

Yang L, Yang L, Tian W, Li J, Liu J, Zhu M . Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol. 2014; 140(5):749-55. DOI: 10.1007/s00432-014-1624-4. View

Wu Y, Antony S, Juhasz A, Lu J, Ge Y, Jiang G . Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines. J Biol Chem. 2011; 286(14):12245-56. PMC: 3069428. DOI: 10.1074/jbc.M110.191031. View

Lesina M, Kurkowski M, Ludes K, Rose-John S, Treiber M, Kloppel G . Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell. 2011; 19(4):456-69. DOI: 10.1016/j.ccr.2011.03.009. View

Dima S, Tanase C, Albulescu R, Herlea V, Chivu-Economescu M, Purnichescu-Purtan R . An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. Pancreas. 2012; 41(7):1001-7. DOI: 10.1097/MPA.0b013e3182546e13. View

10.

Fukuda A, Wang S, Morris 4th J, Folias A, Liou A, Kim G . Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 2011; 19(4):441-55. PMC: 3075548. DOI: 10.1016/j.ccr.2011.03.002. View

11.

Green D . Death and NF-kappaB in T cell activation: life at the edge. Mol Cell. 2003; 11(3):551-2. DOI: 10.1016/s1097-2765(03)00107-2. View

12.

Gupta S, Kannappan R, Reuter S, Kim J, Aggarwal B . Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci. 2011; 1215:150-60. PMC: 3060406. DOI: 10.1111/j.1749-6632.2010.05852.x. View

13.

Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H . CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer. 2008; 124(4):853-61. PMC: 2684108. DOI: 10.1002/ijc.24040. View

14.

Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao P . Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005; 65(19):9064-72. DOI: 10.1158/0008-5472.CAN-05-1330. View

15.

Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Furuse J, Inagaki M . Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer. 2013; 108(10):2063-9. PMC: 3670479. DOI: 10.1038/bjc.2013.174. View

16.

Kuwada Y, Sasaki T, Morinaka K, Kitadai Y, Mukaida N, Chayama K . Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int J Oncol. 2003; 22(4):765-71. View

17.

Egberts J, Cloosters V, Noack A, Schniewind B, Thon L, Klose S . Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 2008; 68(5):1443-50. DOI: 10.1158/0008-5472.CAN-07-5704. View

18.

Wigmore S, Fearon K, Sangster K, Maingay J, Garden O, Ross J . Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol. 2002; 21(4):881-6. DOI: 10.3892/ijo.21.4.881. View

19.

Ju K, Lim J, Kim K, Kim H . Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm Res. 2011; 60(8):791-800. DOI: 10.1007/s00011-011-0335-4. View

20.

Hiraga R, Kato M, Miyagawa S, Kamata T . Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells. Anticancer Res. 2013; 33(10):4431-8. View